Clik here to view.
Avita Medical Announces Submission of U.S. FDA Premarket Approval (PMA)...
VALENCIA, Calif. & PERTH, Australia & LONDON Avita Medical (ASX: AVH) (OTCQX: AVMXY), a regenerative medicine company specializing in the treatment of wounds and skin defects, announced...
View ArticleClik here to view.
Spectrum Pharmaceuticals Highlights Poziotinib Data in Lung Cancer to be...
HENDERSON, Nev. Spectrum Pharmaceuticals, Inc. (NasdaqGS: SPPI), a biotechnology Company with fully integrated commercial and drug development operations with a primary focus in Hematology and...
View ArticleClik here to view.
旅への渇望はDNAに刻み込まれているのか？キュリオ・コレクションbyヒルトンが「好奇心遺伝子プログラム」を立ち上げ
Smart Multimedia Gallery ビデオタイトル QuickTimeで再生 WindowsMediaで再生 米バージニア州マクリーン （ビジネスワイヤ） — あなたは生まれながらに好奇心が旺盛ですか？...
View ArticleClik here to view.
武田在第18届世界肺癌大会上呈报通过枢纽性2期ALTA 临床试验获得的ALUNBRIG™ (brigatinib)数据
马萨诸塞州剑桥和日本大阪 (美国商业资讯) — 武田药品工业株式会社(TSE: 4502)今天宣布，该公司将在国际肺癌研究协会(IASLC)的第18届世界肺癌大会(WCLC)上呈报4篇由公司资助的研究摘要，其中包括一场口头报告，本届大会将于10月15-18日在日本横滨召开。本届会议上的报告将突出强调武田在开发ALUNBRIGTM...
View ArticleClik here to view.
LivaNova和微创医疗宣布Rega起搏器获得中国国家食品药品监督管理总局批准
伦敦 (美国商业资讯)–LivaNova PLC (NASDAQ:LIVN) (“LivaNova”)和微创医疗科学有限公司(HK:00853)（简称“微创医疗”）今天宣布，两家公司在上海组建的合资公司MicroPort Sorin Cardiac Rhythm Management Co. Ltd.（简称“MSC”或“合资公司”）生产的RegaTM起搏器系列获得国家食品药品监督管理总局批准。...
View ArticleClik here to view.
武田薬品、第18回世界肺がん学会議でピボタル第2相ALTA試験から得たALUNBRIG™（ブリガチニブ）のデータを発表へ
米マサチューセッツ州ケンブリッジ & 大阪 （ビジネスワイヤ） — 武田薬品工業株式会社（TSE:...
View ArticleClik here to view.
Seattle Genetics and Takeda Announce Publication in Blood of Final Long-Term...
BOTHELL, Wash. & CAMBRIDGE, Mass. & OSAKA, Japan Seattle Genetics, Inc. (NASDAQ:SGEN) and Takeda Pharmaceutical Company Limited (TSE:4502) today announced final data from the ADCETRIS...
View ArticleClik here to view.
Seattle Genetics and Astellas Initiate Pivotal Trial of Enfortumab Vedotin...
BOTHELL, Wash. & TOKYO Seattle Genetics, Inc. (NASDAQ: SGEN) and Astellas Pharma Inc. (TSE: 4503, President and CEO: Yoshihiko Hatanaka, “Astellas”) today announced dosing of the first patient...
View ArticleClik here to view.
Orthocell Appoints Surgical Specialties as Exclusive Distributor
PERTH, Australia Regenerative medicine company Orthocell Limited (ASX:OCC, “Orthocell” or the “Company”) is pleased to announce it has appointed Surgical Specialties Pty Ltd (Surgical Specialties)...
View ArticleClik here to view.
Avita Medical A$16.9 Million Capital Raising
VALENCIA, Calif. & PERTH, Australia & LONDON Avita Medical (ASX: AVH) (OTCQX: AVMXY), a regenerative medicine company specialising in the treatment of wounds and skin defects, is undertaking...
View ArticleClik here to view.
和铂医药宣布，已授权信达生物制药使用其全人源单克隆抗体转基因小鼠平台开发多种全人源单克隆抗体新药
中国上海，荷兰鹿特丹和美国马萨诸塞州剑桥 和铂医药（Harbour BioMed）宣布，已授权一家中国优秀的创新型生物制药公司信达生物制药（Innovent Biologics, Inc.）使用其拥有全球专利技术的H2L2转基因小鼠平台，开发多领域的全人源单克隆抗体创新药物。...
View ArticleClik here to view.
Harbour BioMed Announces Multi-Year Transgenic Platform Licensing Agreement...
SHANGHAI & ROTTERDAM, The Netherlands & CAMBRIDGE, Mass. Harbour BioMed announced today that it has licensed its patented H2L2 transgenic mouse platform for generating fully human...
View ArticleClik here to view.
Shionogi Inc. and Purdue Pharma L.P. Announce U.S. Availability of Symproic®...
OSAKA, Japan & FLORHAM PARK, N.J. & STAMFORD, Conn. Shionogi Inc. and Purdue Pharma L.P. announced today that Symproic® (naldemedine) 0.2 mg tablets are now available throughout the United...
View ArticleClik here to view.
Novocure Announces Data Presentations at the IASLC 18th World Conference on...
ST. HELIER, Jersey Novocure (NASDAQ: NVCR) announced today five data presentations at the International Associations for the Study of Lung Cancer (IASLC) 18th World Conference on Lung Cancer,...
View ArticleClik here to view.
旅行癖是根植于我们基因的吗？Curio Collection by Hilton推出“好奇基因”项目
Smart Multimedia Gallery ビデオタイトル QuickTimeで再生 WindowsMediaで再生 弗吉尼亚州麦克莱恩 (美国商业资讯)–您天生好奇吗？这个秋季，希尔顿(NYSE: HLT)的14家市场领先品牌之一Curio Collection by...
View ArticleClik here to view.
Anika Announces Regulatory Approval for MONOVISC® in Australia for the...
BEDFORD, Mass. Anika Therapeutics, Inc. (NASDAQ: ANIK), a global, integrated orthopedics medicines company specializing in therapeutics based on its proprietary hyaluronic acid (“HA”) technology,...
View ArticleClik here to view.
GenePeeks Expands Distribution to India with Exclusive Agreement with CORE...
CAMBRIDGE, Mass. GenePeeks, Inc., a computational genomics company focused on transforming disease risk analysis, today announced an exclusive distribution agreement with CORE Diagnostics, a...
View ArticleClik here to view.
武田呈报ALUNBRIGTM (brigatinib)治疗ALK阳性非小细胞肺癌枢纽性2期ALTA试验的更新结果
马萨诸塞州剑桥和日本大阪 (美国商业资讯) — 武田药品工业株式会社(TSE: 4502)今天宣布，枢纽性2期ALTA (ALK in Lung Cancer Trial of AP26113)临床试验数据将于日本标准时间10月16日星期一下午4:30 – 4:40在国际肺癌研究学会(IASLC)第18届世界肺癌大会(WCLC)上进行口述呈报，该试验评估ALUNBRIGTM...
View ArticleClik here to view.
Spectrum Pharmaceuticals Highlights Poziotinib Data in Non-Small-Cell Lung...
HENDERSON, Nev. Spectrum Pharmaceuticals, Inc. (NasdaqGS: SPPI), a biotechnology company with fully integrated commercial and drug development operations with a primary focus in Hematology and...
View ArticleClik here to view.
Interim Analysis of Ignyta’s Entrectinib Suggests Potential Best-in-Class...
SAN DIEGO Ignyta, Inc. (Nasdaq: RXDX), a biotechnology company focused on precision medicine in oncology, today announced updated results from its clinical trials, including the STARTRK-2 trial, of...
View Article